Ocular Myasthenia Gravis

Ocular myasthenia gravis (OMG) is a medical condition defined by fatigable weakness of the ocular muscles, which leads to drooping of the eyelids and double vision. It is the most common form of myasthenia, an autoimmune disorder that causes weakening of the skeletal muscles. OMG is caused by antibodies, produced by the immune system, that disrupt the normal interaction between the nerve and muscle cells. Treatment primarily consists of medications that suppress the patient's immune system and reduce the severity of symptoms. Additionally, surgery may be used to correct severe cases that inhibit the patient's vision. Ocular myasthenia gravis is considered a serious disorder, as it can lead to permanent damage of the eye muscles, but proper diagnosis and treatment can successfully manage the condition.

← International Journal of Glaucoma

Related Articles

7 article(s) found
Management of Absent Capsular Support with a new Intraocular Lens Design
Full-text HTML Download PDF Download XML
Ocular Manifestations of Vitamin A Deficiency Among the Rural Pre-School Children of North India
Full-text HTML Download PDF Download XML
Rapidly Progressing Visual Loss Associated with Optic Nerve Head Drusen: Is there A Role For Lowering Intraocular Pressure?
Full-text HTML Download PDF Download XML
Transiently Raised IOP Equivalent to That Experienced During Ocular Surgery Causes Moderate Inflammation but does not Affect Retinal Function or Result in Retinal Ganglion Cell Loss in An Animal Model
Full-text HTML Download PDF Download XML
Myasthenia and Antisynthetase Antibody Syndrome: A Case Report in Togo
Full-text HTML Download PDF Download XML
Retrograde Amnesia and Disorientation after Intraocular Injection of Anti-VEGF Agents
Full-text HTML Download PDF Download XML
Case Series on Chiasmal Lesions with Ocular Manifestations seen at the Eye Center of a Tertiary Government Hospital in Philippines
Full-text HTML Download PDF Download XML